IndividuALLytics® Team Leaders
IndividuALLytics® is excited about blending the unique N-of-1, Group, Behavior, and Computer Science experts to make a difference in people’s lives with chronic health challenges. We have included a unique blend of collaborative business leaders to support rapid science validation and value creation to help important health communities and their leaders.
Co-Founder, President, & CEO
Dennis has led high growth teams at IBM, Oracle, E&Y Consulting, and several successful new technology startups, including helping Telxon and Proforma support growth that generated sizable business exits. His business development experience helped rapidly get new products commercialized and ramped up sales to millions to hundreds of millions $ per year. Dennis has been instrumental in getting executives, finance, marketing, sales, operations, service, and engineering/development aligned to engage targeted customers to deliver high value that obtained high growth and shareholder value. He has also managed two successful business restructuring projects and winddown. His quality systems background blended with feedback from hundreds of mental health, medical, and bio-systems experts plus patient health advocates identified challenges brought the need for N-of-1 science to the forefront. He is a Mechanical Engineer with minor in business from MIT that helps teams succeed by delivering world class solutions to previously big unmet needs and leveraging breakthrough technologies with effective strategic intellectual property protection.
Steven Schwartz, Ph.D.
Co-Founder, CSO, Head of Clinical Delivery Design
Steven has been involved in healthcare delivery and research for 30 years and has led outcomes evaluation and clinical trial coordination in a variety of settings including healthcare delivery systems, digital health technology, data analytics and the pharmaceutical industries. As part of the Behavioral Science Team that architected and evaluated the suite of HealthMedia digital health coaching products prior to, during, and after the company’s acquisition by Johnson and Johnson in 2008, Dr. Schwartz has been part of the digital innovation curve in healthcare for many years. He has published extensively in peer review science and industry trade publications. He has spoken on key health and technology topics locally, nationally and internationally. As a Boarded Clinical Psychologist, Dr. Schwartz has significant theoretical and practical expertise in (Cognitive) Behavioral Psychology, Learning Theory, Positive Psychology, Behavioral Economics, Clinical Trials Design, Program Evaluation, Human-Centered and Instructional Design, Gamification and N-of-1 Individual Science methodology. Dr. Schwartz is co-inventor on pending patent to enhance personalized evidenced-based medical and non-pharmaceutical micro-interventions. The invention leverages predictive population statistics, AI, wearable sensors, and N-of-1 simple-to-understand accurate personalized IndividuALLytics Quotients™ (IAQplus™) to give medical professionals new level of personalized predictive analytics cost-effectively to aid improved productive patient conversations and better outcomes. This cloud-based Software as a Service solution can easily be added to health and chronic disease apps to power better outcome results and improve measurable value delivered.
Janet Greenhut, MD, MPH
Chief Medical Officer
Dr. Greenhut is a physician with 20 years of clinical experience in primary care and preventive medicine and 17 years of experience developing digital health coaching programs for physical and mental health. Her clinical experience includes working for the US Public Health Service in an underserved area and is maintaining a private practice in Ann Arbor, Michigan. She worked for HealthMedia starting in 1999 helping to develop a suite of innovative online health behavior change and disease management programs. She continued with the company as Medical Researcher and Consultant through its acquisition by Johnson & Johnson in 2008 until 2012. In 2013-2014, Dr. Greenhut worked for the Health Management Research Center at the University of Michigan developing a health risk assessment. She returned to J&J Health and Wellness Solutions in 2014-2017 as Medical Consultant. In 2018, Dr. Greenhut co-founded a nonprofit company, Narrative Dimensions, which offers workshops for people who are dealing with the challenges of chronic illness.
VP Market & Product Development, Investor Relations Director
Maureen has over 32 years of experience in the Consumer-Packaged Goods, Healthcare, Pharmaceutical, Telecommunications and Retail industries. Specializing in IT Strategies, Product Commercialization, and Business Development, she served on the Board of Directors for a new start up business within the world’s largest healthcare company focused on the preventable healthcare crisis which is costing over $1 trillion annually from productivity loss due to chronic diseases. Her role in leading the due diligence of over 10 companies targeted for acquisition with two successful Integrations was critical in developing the growth plan for the business. She has keen business insight and in-depth knowledge of starting up and improving existing business operations while leading strategic and tactical IT and Sales/ Marketing and Business Development that enable her to significantly impact the bottom line of the business. She has held leadership positions responsible for all functional areas of the Value Chain including B2B and DTC Digital Strategies for 32 OTC Products such as Tylenol, Motrin, Imodium AD and Concerta. She was hand-picked to develop and lead an IT team with the Internal Incubators for Advanced Technologies focused on building a Brain Fitness Franchise aimed at becoming the Global Leader in consumer-preferred, clinically-validated solutions for Cognitive Health, as well as, Digital Health Coaching Digital Coaching Solutions grounded in Behavioral Science. Her natural relationship management skills in working with all levels of Executives / Teams has earned her the trust of those she works with and has awarded her a broad Global Network that has proven instrumental in successful Product Commercialization around the world.
Shannon Nash, LCSW, MBA
MBA, Director Clinical Operations
Most recently Shannon has worked as a direct patient care Licensed Clinical Social Worker. Previously she has worked in many areas of health care including Home Care, Skilled Nursing, Hospice & Palliative Care, Ambulatory, Inpatient Hospital, Insurance and the Emergency Department. Each experience has provided her the opportunity to view health care and health care administration through a different lens. She has a passion in development and training of staff, process improvement, program management, and for great quality patient experience. She recently completed her MBA-Health Administration program in 2020 from the University of Colorado. Shannon earned her MSW from Wayne State University and Bachelor of Social Work from Western Michigan University.
Co-Founder, Chief Marketing Officer
Collin has led marketing and sales growth strategies in solar, software, engineering, life science, and manufacturing industries. He has helped companies grow in difficult times and despite limited resources as a veteran in marketing and sales with a focus on providing an organized and disciplined approach to integrating both into the overall business plan. He has successfully led all aspects of companies’ growth, including marketing, sales, business planning and development, major account penetration, channel expansion, marketing communications and recruiting. In addition, he has managed change with marketing and sales teams, directed strategic growth plans, integrated product diversification and initiated strategic global sales realignment to increase competitive position. Previously, he held a variety of domestic and international marketing and sales executive positions with General Electric, Gates Energy Products, W.R. Grace, Raybestos-Manhattan, United Solar Systems and a HP reseller. He has a degree in Marketing from the University of Massachusetts.
IAQplus Analytics Programming
Experience cloud programmer and software design specialist. He has a Bachelor of Computer Science Engineering with a Minor in Mathematics from the University of Michigan. His main focus is in artificial intelligence, although he also has an interest in medical applications. He has worked on projects to detect cancer in brain scans and participated in a Public Health Hackathon aimed at improving access to care in Metro Detroit communities. Max also has experience with utilizing AWS cloud services to connect multiple data sources and applications into a single product. He is the lead product engineer on IAQplus dashboards and N-of-1 predictive analytics engine. He is starting on a path for Masters and Ph.D. computer science programs at University of Michigan.
Dr. Richard Bedrosian
With over 40 years of experience. He has been a pioneer in developing digital programs for improving physical and mental health. He was founder/CEO of MySelfHelp.com, which offered online programs for mental health problems. He was Principal Investigator on seven SBIR from the National Institutes of Health, later serving as ad hoc reviewer for SBIR applications to NIH. In 2006, MySelfHelp.com, was acquired by HealthMedia, which was acquired by Johnson and Johnson in 2008. From 2006 to 2008, Dr. Bedrosian served as Director of Behavioral Health for HealthMedia, continuing in that role for J&J Health & Wellness Solutions until 2016. Dr. Bedrosian currently consults with companies developing and commercializing innovative products targeting behavioral health, wellness, and disease management. Dr. Bedrosian is an Instructor in Psychiatry at the University of Massachusetts Medical School, where he teaches cognitive-behavior therapy. He is author of numerous publications focused on depression, eating disorders, and digital coaching and has taught and mentored therapist at the national and international level.
Jeremy Albright, Ph.D.
Statistics and Data Visualization Advisor
Founder and CEO of a data science consulting firm. He has over ten years of experience working with clients from business, finance, government, and academia to glean actionable insights from complicated data. For example: (1) a multinational market research firm relied on slow, error-prone process of manually creating and summarizing data collected from its clients, so Jeremy led development of an app to automate the data management and certain analytic steps, reducing tasks that took days down to seconds and saving the company tens of thousands of dollars in labor costs per year; (2) New Jersey-based hedge fund sought assistance determining optimal machine learning algorithm to predict movements in US equities, so Jeremy developed a deep learning-based model that has consistently outperformed the larger market for nearly two years, including during periods of high volatility, and helping the fund continue to attract new investors; and (3) Legal counsel required expert statistical testimony on behalf of a whistle-blower in a case alleging fraudulent Medicare billing. Albright’s data analysis and opinions were used in negotiations that led to a $35 million settlement favoring the whistle-blower. Jeremy has led the robust use cases to combine population health (group average) and individual (N-of-1) science and early computer simulations to support product and solution development.
Managing Director, Pharmaceutical Innovation
Dave’s competencies include thought leader development and engagement, strategic planning, brand differentiation, direct to consumer advertising and customer retention. Dave is adept at analyzing the pharma and provider marketplace as it relates to mHealth (mobile health) initiatives to determine issues, needs, opportunities, desires and concerns. Dave’s accomplishments include the development of the Restasis direct to consumer advertising campaign, development of the Restless Leg Syndrome market for Glaxo’s brand Requip, the launch of Glaxo’s brand Zyban for smoking cessation and consulting with Allergan Pharmaceuticals to help shape their marketing strategy for several Botox’s therapeutic indications including migraine and overactive bladder. Dave was one of the founders of HealthMedia, a spinoff from the University of Michigan that was the first company to apply science-based behavior change coupled with the ability to personally tailor messaging on a mass scale that lead to several pharmaceutical company strategic customer relationships worth millions of dollars.
Brigid Byrd, Ph.D.
Bio-psychosocial Health Consultant and Connected Care Researcher
Research in Kinesiology with a specialization in Sport and Exercise Psychology from Wayne State University. Throughout her academic career she has developed expertise in the biopsychosocial model of health, behavioral science as applied to sport and exercise settings, measurement assessment and research methodology. Brigid has experience assessing psychosocial factors associated with exercise and health antecedents and outcomes in various populations including elderly adults, disabled athletes, NCAA Division I athletes, novice exercisers, and underserved children. Her expertise aligns with IndividuALLytics’ goal of providing best practices regarding exercise and psychosocial measurements to enhance digital health applications.
Software Application Development Manager
Andrew has managed software development as an Application Development Manager, Product Manager and Project Manager for over 25 years. Companies he has worked for include Capital One, Disney, CA and Wells Fargo. Technologies include rich web front-ends (e.g. Angular, React), data-driven web applications (Java, .NET, Python, NodeJS), business intelligence, content management, APIs, interfaces and native mobile apps. Before he was a manager, Andrew was a Senior Web Developer for several interactive agencies.
Science and Business Advisors
Dr. Gordon Guyatt
Evidence-Based Medicine and N-of-1 Science Advisor
Gordon is a McMaster University Distinguished Professor. His work has focused on Evidence-based Medicine and promoting high quality health care without financial barriers for all Canadians; his Order of Canada citation acknowledges both contributions. He has been honored as Canadian Institute of Health Research researcher of year and a member of the Canadian Medical Hall of Fame. He presents on these topics internationally and he is cited often on N-of-1 science and evidence-based medicine.
Neal Fairbanks, CIO
Neal is a Senior Software Product Development Leader. He is an experienced enterprise software developer and manager with product development, SaaS, Cloud, HIPAA, high security, AI/big data, and mobile expertise. Neal manages programming team to hit key quality and time milestones. For example, his team supported implementing medical application with one of the first Microsoft SQLserver implementations that was truly HIPAA compliant personal information management system for a client.
Medical Device Business Development Advisor
David has managed the launch of numerous products into the life sciences global marketplace for over 30 years as a business development, sales and marketing executive. He has helped companies raise angel, VC and public (IPO) capital to take their products/services from concept to the commercial market. After 10 years with a J&J company, he was recruited to conduct a turn-around of a Warner-Lambert division in a flat market which was completed in one year.
Digital Health and Pharmaceutical Business Development Advisor
Raj was a co-founder of a diabetes start-up which helped lower A1C by bringing a 360 degree view of the diabetic, actionable, at the point of care. He is also an angel investor, a Fortune 50 career professional and is deeply involved in start-up mentoring. He has 20 plus years of experience in growing biotech, pharma, med tech, genomics and healthcare businesses for Express Scripts, Price Waterhouse, Accenture, KV Pharmaceuticals, other S&P 500 companies and startups. He has helped many businesses increase profits significantly, has completed over $1B M&A deals and co-founded 5+ startups. He has been involved with 15+ Detroit based start-ups as an advisor, investor, coach or mentor and sits on the advisory board of 2 life science companies. In addition to coaching XLerateHealth startups, Raj also works with startups at Centrepolis working with small manufacturers and hardware entrepreneurs. Currently, he is involved in Eiconica, N-gaje and in K-Wav as a Senior Advisor. Raj received a B.E. from the University of Bombay, an M.S. from the Univ. of Toledo, and an MBA from Cornell University.
Other Key Team Members/Partners/Collaborators
Personal Care Team partners – Family members, friends, and others supporting health care change goals in the healthy, at risk, and ill populations and individuals.
Patient-Consumer Health Community Leaders – Advocates for chronic condition, health and quality of life improvement
Alzheimer’s Disease/Dementia Medical and Care Leaders – Expertise on special needs for ALZD/ALZ patient and family caregiver care
Digital Health Application Software Partners – Selection of the best quality and easy to use tools including Fitbit, GenusConnect and Welkin Health.
Wearable/Portable/Medical Device Sensor Partners – Cost effective, easy to use key data collection Fitbit
Non-Medical Home, Respite Care and Nursing Home Partners – Able to offer point of patient care with increased value
Health Care System Partners – Develop best in class complex chronic condition capabilities with ability to optimize quality of life improvements, IAQplus Care Providers
Payer Partners – Use validation to demonstrate improved health, quality of life, with good ROI/utilization
Domain Expert Partners – Chronic disease & disorder experts leading patient centric engagement
Pharmaceutical Consultants – Brand manager, Clinical Trial leaders, and Pharmacist with drug launch expertise with digital health service wrap expertise
Pharmaceutical/Bio-Tech Partners – Visionary collaborators looking to leverage personalized behavior treatments with traditional treatments and help bridge genetic knowledge and lack of knowledge for complex conditions via identified behavior phenotypes